Velikova G, Stark D, Selby P
ICRF Cancer Medicine Research Unit, St James's University Hospital, Leeds, U.K.
Eur J Cancer. 1999 Oct;35(11):1571-80. doi: 10.1016/s0959-8049(99)00193-8.
The objective of this article is to aid clinicians in understanding the current state of the development and application of quality of life (QOL) instruments as outcome measures in cancer clinical research and practice. As a result of the achievements of the past two decades, the concept of QOL has been defined and many reliable and valid measurement tools have been developed. The two main approaches to QOL assessment, psychometric-based and utility-based, are discussed together with a brief description of the strategies for meaningful interpretation of QOL profiles. QOL measures in oncology have the potential to be used to study populations in randomised clinical trials, to aid patient-clinician interactions in routine practice and to support policy decision making and economic evaluation of healthcare provision.
本文的目的是帮助临床医生了解生活质量(QOL)工具作为癌症临床研究和实践中的结局指标的发展和应用现状。由于过去二十年所取得的成果,生活质量的概念已得到明确界定,并且已经开发出许多可靠且有效的测量工具。本文讨论了生活质量评估的两种主要方法,即基于心理测量学的方法和基于效用的方法,并简要描述了对生活质量概况进行有意义解读的策略。肿瘤学中的生活质量测量方法有潜力用于随机临床试验中的人群研究,在常规实践中辅助患者与临床医生的互动,以及支持医疗保健提供方面的政策决策和经济评估。